embody vs altRx vs wellmedr: The Budget GLP-1 Trio
Last updated: Aug 16, 2026
We may earn a commission when you visit providers through links on this page - it never affects our rankings (how we stay objective). This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
Here’s the short version
These three providers own the budget end of the compounded GLP-1 market, and they get there by different routes: wellmedr's $59 rewards a 12-month plan, embody's $69 is flat with zero commitment, and altRx's $89 adds the option to switch to brand-name Ozempic or Zepbound later. Same active ingredients across all three - the matrix below is really a comparison of commitment terms, logistics and optionality.
embody vs altRx vs wellmedr: side by side
Real published prices and terms - the differences that actually decide this matchup.
| embody | altRx | wellmedr | |
|---|---|---|---|
| Semaglutide | $69/mo, flat at every dose | $89/mo (reg. $199), flat at every dose | $59/mo (12-month plan), same price at every dose |
| Tirzepatide | $119/mo | $149/mo (reg. $299) | $99/mo |
| Billing & commitment | Monthly - no commitment, cancel anytime | Monthly - pause or cancel anytime; Buy Now, Pay Later | Monthly billing - best rate locks on a 12-month plan |
| Shipping | Free 1-2 day, tracked & insured | Free nationwide delivery | Free, every 4 weeks, discreet packaging |
| Support | Licensed doctors, medical director & nursing team | Licensed provider review (physician, PA, or NP) | Medical Weight-Care Coach on every plan |
| Guarantee / refund | Full refund if you're not approved | - | Weight-loss warranty (terms on site) |
| Standout | LegitScript-certified; 503A pharmacies | Brand-name shelf: Ozempic $1,149 · Zepbound $1,249 · Wegovy $1,579 | 1M+ patients; board-certified specialists |
Our verdict
Pick by your commitment appetite. Committed for a year and price-first: wellmedr's $59 is unbeatable. Want the freedom to stop anytime: embody's flat $69 with 1-2 day shipping and a refund-if-not-approved policy is the cleanest deal in the market. Think brand-name might be in your future: altRx is the only one of the three with a brand shelf, and its BNPL spreads the cost. There's no wrong answer here on legitimacy - all three run licensed-provider review and regulated pharmacies.
embody vs altRx vs wellmedr: FAQs
Which of embody, altRx and wellmedr is cheapest?
wellmedr has the lowest headline price at $59/month for compounded semaglutide, but that rate locks on a 12-month plan. embody charges a flat $69/month with no commitment, and altRx $89/month with pause-anytime terms and Buy Now, Pay Later. On tirzepatide: wellmedr $99, embody $119, altRx $149.
Do all three require a prescription?
Yes. All three are telehealth providers where a licensed clinician reviews your medical intake and decides whether GLP-1 treatment is appropriate - approval is not automatic at any of them. Medication is dispensed through licensed pharmacies.
Which ships fastest?
embody ships free in 1-2 days, tracked and insured. altRx offers free nationwide delivery on standard timelines, and wellmedr ships free every 4 weeks in discreet packaging aligned to its dosing cycle.
Break it down two at a time
The head-to-head comparisons between these providers.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)